Financials
- Market Capitalization 129.29 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
29.59
Fiyat/satışlar oranı
9.75
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 182 | MRNA Moderna, Inc. - Common Stock | 225.00 USD | +14.21% | +17.49% | +55.17% | +725.69% | 89.83 B USD | ||
| 218 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 746.54 USD | +0.94% | +1.66% | -5.38% | +35.24% | 76.86 B USD | ||
| 309 | ARGX argenx SE - American Depositary Shares | 825.03 USD | +0.78% | -10.34% | -17.87% | +3.55% | 51.06 B USD | ||
| 367 | RVMD Revolution Medicines, Inc. - Common Stock | 189.76 USD | +0.87% | -8.63% | -6.75% | +242.53% | 40.67 B USD |